A NEW STANDARD OF CARE
While gene expression testing adds significantly to the information provided by tumor grading, it can take up to six weeks to complete and costs more than $4,000. And because it’s used primarily with excisional specimens, it requires significant time and labor of pathology. Even then, gene expression testing still may rely on the subjective tumor grading in its risk score, and the limited reporting features can lead to clinical ambiguity.
Current standards of care in oncology can be subjective, leading to a high percentage of tumors receiving intermediate grading. As a result, many patients are forced to anxiously await the results of gene expression testing for over a month, delaying vital decisions regarding their care plan.
65%
Intra-observer variations in grading results***
56%
of Grade 3 tumors are low risk**
22%
of Grade 2 tumors are high risk**
78%
of Grade 2 tumors are low risk**
*Sparano, New England Journal of Medicine. 2018
**Based on a retrospective longitudinal study of more than 2,000 cancer cases. Fernandez, G., Prastawa, M., Madduri, A.S. et al. Breast Cancer Research 2022’.
***Paik, New England Journal of Medicine, 2004
.avif)
LEARN MORE. MORE QUICKLY.
The Morphology Feature Array® identifies recurrence risk with the same accuracy and reliability as gene expression testing.
Using PreciseBreastTM as well as gene expression or visual pathologic analysis delivers benefits for patients, physicians, and payors.
.svg)
Data to drive precise reporting of tumor recurrence risk
Faster results lessen anxiety for patients
.svg)
Lower overall costs for treatment and testing
Availability to 100% of eligible patients
our process
PreciseBreast is designed specifically to improve the multidisciplinary team’s workflow, providing a complement to pathological tumor grading and gene expression testing.
Screening / Detection
Biopsy & Diagnosis
Resection
Tumor Grading
Tumor Staging
Gene-Expression Testing
Care Planning
The results of slow or unavailable gene-expression testing can impact patients and their anxiety levels during a critical time in their lives. These are their stories of how PreciseBreast might have made a difference.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere eros dolor interdum nulla, ut commodo diam liber eros dolor interdum nulla, ut commodo. Learn more here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere eros dolor interdum nulla, ut commodo diam liber eros dolor interdum nulla, ut commodo. Learn more here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere eros dolor interdum nulla, ut commodo diam liber eros dolor interdum nulla, ut commodo. Learn more here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere eros dolor interdum nulla, ut commodo diam liber eros dolor interdum nulla, ut commodo. Learn more here
Contact us today to learn more about PreciseBreast.
